NanoViricides (NNVC) Narrows Q1 Loss

NanoViricides (NYSE: NNVC) reported Q1 EPS of $0.00, versus ($0.04) reported last year. Loss from operations narrower from $1.89 million down to $1.69 million.

For earnings history and earnings-related data on NanoViricides (NNVC) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance